EUVIMEDEUVIMED entdecken
Crossref

The Alamandine/MrgprD as a Key Player in Antiresorptive Effects in an Osteoporosis Experimental Model

Letícia Cristina Dias Lima, Isabella Ramos Cavalcante, Felipe Emanuel Oliveira Rocha, Jader Oliva Jorge, Talita Martins, Mila Fernandes Moreira Madeira, Maria José Campagnole-Santos, Soraia Macari, Clésia Cristina Nascentes, Eduardo Henrique Martins Nunes, Celso Martins Queiroz-Junior, Robson Augusto Souza Dos Santos und 2 weitere

Calcified Tissue International · 09.03.2026 · 117 (1)

DOI: 10.1007/s00223-025-01465-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Calcified Tissue International, online erschienen am 09.03.2026. Verfasst von Letícia Cristina Dias Lima und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Morphology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Av. Antonio Carlos, 6627, Pampulha, Belo Horizonte,…. Hauptthemen laut MEDLINE: Osteoporosis, Bone Resorption, Oligopeptides, Receptors, G-Protein-Coupled. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Amparo à Pesquisa do Estado de Minas Gerais.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The renin-angiotensin system plays a key role in bone metabolism. While the classical renin-angiotensin system axis promotes bone resorption, the counter-regulatory axis, including alamandine via MrgprD receptor, favors bone formation. This study evaluated the therapeutic effects of alamandine in a model of osteoporosis. In vitro, alamandine reduced osteoclast activation and size in a MrgprD receptor-dependent manner. In vivo, ovariectomy-induced osteoporosis reduced bone parameters, and alamandine reversed trabecular bone loss in wild-type mice but not in MrgprD knockout mice, demonstrating the essential role of the receptor. Alamandine also reduced serum calcium and phosphorus levels in ovariectomized wild-type mice, with no effect on ovariectomized knockout animals. Furthermore, modulation of iron levels differed between genotypes, suggesting the involvement of ferroptosis-related pathways. Histological analysis revealed an increase in the number of osteoblasts and osteocytes in wild-type mice treated with alamandine, corroborating its role in osteogenic differentiation, possibly via the AMPK/eNOS pathway. In contrast, alamandine exacerbated bone resorption in ovariectomized MrgprD knockout mice, potentially through alternative renin-angiotensin system receptors. In conclusion, alamandine increases bone formation and reduces resorption through MrgprD receptor signaling, highlighting its potential as a therapeutic agent in osteoporosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoporosisBone ResorptionOligopeptidesReceptors, G-Protein-CoupledAnimalsMiceFemaleMice, KnockoutDisease Models, AnimalOsteoclastsOvariectomyOsteogenesisRenin-Angiotensin SystemMice, Inbred C57BL

Stichwörter der Autor:innen

Bone ResorptionMrgprDOsteoclastsOvariectomyRenin-Angiotensin System

Substanzen

alamandineOligopeptidesReceptors, G-Protein-Coupled

Autor:innen und Institutionen

  • Department of Morphology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Av. Antonio Carlos, 6627, Pampulha, Belo Horizonte, 31270-901, Brazil.
  • Department of Restorative Dentistry, Dentistry School, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Department of Metallurgical and Materials Engineering, Engineering School, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Department of Microbiology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Department of Physiology and Biophysics, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Department of Chemistry, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais

Zitieren

APA

Lima, L. C. D., Cavalcante, I. R., Rocha, F. E. O., Jorge, J. O., Martins, T., Madeira, M. F. M., Campagnole-Santos, M. J., Macari, S., Nascentes, C. C., Nunes, E. H. M., Queiroz-Junior, C. M., Dos Santos, R. A. S., Moreira, P. R., & de Sá, M. A. (2026). The Alamandine/MrgprD as a Key Player in Antiresorptive Effects in an Osteoporosis Experimental Model. Calcified Tissue International, 117(1). https://doi.org/10.1007/s00223-025-01465-8

Vancouver

Lima LCD, Cavalcante IR, Rocha FEO, Jorge JO, Martins T, Madeira MFM, et al. The Alamandine/MrgprD as a Key Player in Antiresorptive Effects in an Osteoporosis Experimental Model. Calcified Tissue International. 2026;117(1). doi:10.1007/s00223-025-01465-8

BibTeX
@article{Lima2026,
  author = {Lima, Letícia Cristina Dias and Cavalcante, Isabella Ramos and Rocha, Felipe Emanuel Oliveira and Jorge, Jader Oliva and Martins, Talita and Madeira, Mila Fernandes Moreira and Campagnole-Santos, Maria José and Macari, Soraia and Nascentes, Clésia Cristina and Nunes, Eduardo Henrique Martins and Queiroz-Junior, Celso Martins and Dos Santos, Robson Augusto Souza and Moreira, Paula Rocha and de Sá, Marcos Augusto},
  title = {The Alamandine/MrgprD as a Key Player in Antiresorptive Effects in an Osteoporosis Experimental Model},
  journal = {Calcified Tissue International},
  year = {2026},
  volume = {117},
  number = {1},
  doi = {10.1007/s00223-025-01465-8}
}
Kostenlos starten →